December 17, 2021
Ocumetra was founded in 2020 by Professor Ian Flitcroft and Professor James Loughman, leaders in the field of myopia management. Designed to support ECPs who provide myopia management to their patients, Ocumetra’s portfolio includes interactive ocular growth charts, myopia treatment efficacy analytics, risk indicators, and other clinical decision support tools, such as the Refractogram. The Refractogram makes advanced myopia treatment accessible to all, providing evidence-based, detailed graphical and numerical indicators of treatment efficacy.
Ocuco has announced a minority investment in Ocumetra, in which Leo Mac Canna, Ocuco’s CEO, joins Ocumetra’s board, and Ocumetra’s machine learning tools will be integrated with Ocuco’s next-generation, cloud-hosted practice management software.
John Sailer, Editor-in-Chief of Review of Myopia Management, interviewed all three about how Ocumetra will help make myopia management accessible to eye care professionals throughout the world and how Ocuco will help make that happen. Learn more about this partnership at this RMM News Brief.
 |
 |
 |
Ian Flitcroft (left), James Loughman (center), and Leo Mac Canna (right)
